CECentral.com

International Journal of Advances in Rheumatology (Vol. 5, No. 2)

Activity Details

Credit Type:AMA PRA Category 1 (CME)
Credit/Hours: 2.00 (CME)
Cost: Free
Released: Aug 1, 2007
Expires: Aug 31, 2008
System
Requirements:
Adobe Acrobat Reader Adobe Acrobat Reader
Activity Rating: 0 / 5 Stars
0 Total Rating
Rate This Activity:

Faculty

 This activity has 6 faculty members associated with it.
Click Here to View All
Martine De Vos Martine De Vos, MD
Director, Clinical Department Gastroenterology/Hepatology
Head of the Academic Department of Internal Medicine
Ghent University Hospital, Belgium

Eric S.  Hart Eric S. Hart, PsyD
Post-Doctoral Fellow, Neuropsychology and Rehabilitation Psychology
University of Missouri-Columbia

Tom Huizinga Tom Huizinga, MD (Editor)
Chairman of Rheumatology
Leiden University Medical Center, Leiden, The Netherlands

Jerry C.  Parker Jerry C. Parker, PhD
Associate Dean for Clinical Research and Development
University of Missouri-Columbia School of Medicine

Annette H.  Van der Helm-Van Mil Annette H. Van der Helm-Van Mil, MD
Department of Rheumatology
Leiden University Medical Center, The Netherlands

Sara M.  Walker Sara M. Walker, MD
Professor of Internal Medicine
Missouri University School of Medicine
Co-Investigator
Missouri Arthritis Rehabilitation Research and Training Center (MARRTC)

Needs Statement

Each issue of the International Journal of Advances in Rheumatology will present carefully constructed, leading (review) articles, written by practicing rheumatologists and developed to equip readers with practical knowledge of the area under discussion. These articles are commissioned to support particular educational themes identified by the Editors-in-Chief, Editorial Advisory Board and readers. This issue of the International Journal of Advances in Rheumatology presents three such leading articles.

Target Audience

This activity is designed to meet the educational needs of rheumatologists and other clinicians involved in the management of patients with rheumatic diseases.

Objectives

1. Discuss the natural disease course of undifferentiated arthritis;
2. Discuss the recently constructed model that estimates the likelihood of progression to RA in individual patients with undifferentiated arthritis;
3. Discuss the biological responses associated with stress;
4. Discuss the relative merits of psychopharmacological intervention and self-management;
5. Discuss the gut–joint enteropathy seen in Crohn’s disease and spondyloarthropathy;
6. Discuss the central role of TNF-α in Crohn’s disease and spondyloarthropathy.

Accreditation

Medicine
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the University of Kentucky College of Medicine and Remedica Medical Education. The University of Kentucky College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The University of Kentucky College of Medicine designates this educational activity for a maximum of 2.00 AMA PRA Category 1 Credits™. Each physician should claim only those hours of credit actually spent in the educational activity.

The University of Kentucky College of Medicine presents this activity for educational purposes only. Participants are expected to utilize their own expertise and judgment while engaged in the practice of medicine. The content of the presentations is provided solely by presenters who have been selected for presentations because of recognized expertise in their field.

Faculty Disclosure

Dr. Breedveld reports relevant fiancial relationships with Abbott, Schering-Plough, Wyeth. 

Dr. Weinblatt reports relevant fiancial relationships with Abbott, Alza, Amgen, AstraZeneca, BioAssets, Biogen Idec, Bristol-Myers Squibb, CanFite, Celgene, Centocor, CombinatoRx, Critical Therapeutics, Eisai, EntreMed, Genentech, Gilead, Lilly, Merrimack, Merck, Millennium, Novartis, Pfizer, Praecis, Proprius, Rigel, Roche, Sanofi-Aventis, Scios, Serono, Synta, TAP, Trubion, Wyeth, UCB, Vascular Biogenics.

None of the authors report any relevant financial relationships with commercial interests of healthcare products or services related to this activity.


Activity Sponsorship

This activity is jointly sponsored by the University of Kentucky and Remedica Medical Education.
Supported by an unrestricted educational grant from Abbott Laboratories.
© 2008 University of Kentucky, Colleges of Pharmacy & Medicine
Privacy Statement · Feedback · About CECentral.com